ORIGINAL RESEARCH
Published on 14 May 2025
Evaluation of drug interactions in outpatients taking antipsychotic medications
doi 10.3389/fphar.2025.1590167
- 410 views
- Frontiers in Psychiatry
- Psychopharmacology
- Research Topics
- Enhancing Therapeutic Strategies: A Focus on Pharmacovigilance in New Wave Antidepressants and Antipsychotics
Enhancing Therapeutic Strategies: A Focus on Pharmacovigilance in New Wave Antidepressants and Antipsychotics
2,035
Total downloads
10k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 07 Mar 2025
Postmarketing Safety Assessment of the Novel Postpartum Depression Drug, Zuranolone: Evidence from Real-World Pharmacovigilance Analysis Based on the FDA Adverse Event Reporting System (FAERS)
doi 10.3389/fpsyt.2025.1517773
- 363 views
BRIEF RESEARCH REPORT
Published on 05 Mar 2025
Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States: the potential effects of evergreening
doi 10.3389/fpsyt.2025.1450111
- 639 views
- 1 citation
ORIGINAL RESEARCH
Published on 24 Feb 2025
Post-marketing safety surveillance of vortioxetine hydrobromide: a pharmacovigilance study leveraging FAERS database
doi 10.3389/fpsyt.2025.1532803
- 1,365 views
CASE REPORT
Published on 07 Nov 2024
Vortioxetine as an alternative treatment for somatic symptom disorder: case report
doi 10.3389/fpsyt.2024.1496072
- 2,124 views
- 2 citations
REVIEW
Published on 25 Sep 2024
Exploring cariprazine as a treatment option for varied depression symptom clusters
doi 10.3389/fpsyt.2024.1442699
- 3,034 views
Published in
Frontiers in Psychiatry
Psychopharmacology
Mood Disorders
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: